Certified by Founder Lodge
Bain Capital
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $12,500,000
79 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bain Capital is one of the world’s leading alternative investment firms. More than 1,200 Bain Capital employees work together at locations in Boston, Chicago, New York, San Francisco, Palo Al
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 16 ,2022 | Series A | $12,500,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
 PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
 Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
 Overview |
February, 21 ,2022 | Series A | $10,000,000 |
 CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
 SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
 Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 Atmos |
November, 16 ,2022 | Series A | $12,500,000 |
 Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
 Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
 Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Releaf |
January, 13 ,2023 | Pre Series A | $3,300,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
 HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| PeopleFund |
January, 18 ,2023 | Series C | $20,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
 Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Surf Internet |
February, 13 ,2023 | Unknown | $100,000,000 |
 LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| Alloy Automation |
March, 01 ,2022 | Unknown | $27,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Overview |
February, 21 ,2022 | Series A | $10,000,000 |
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| Swoogo |
February, 08 ,2022 | Series B | $20,000,000 |
 1440 Foods |
December, 19 ,2023 | Unknown | |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Hometap |
January, 25 ,2022 | Series B | $245,000,000 |
 Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Zero Hash |
January, 12 ,2022 | Series D | $105,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Blackpoint Cyber |
June, 12 ,2023 | Unknown | $190,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
 Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| LULA(US) |
August, 04 ,2023 | Series B | $35,500,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
 Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| 1440 Foods |
December, 19 ,2023 | Unknown | |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
 Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Navro (formerly Paytrix) |
February, 13 ,2024 | Unknown | $14,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
| Angitia Biopharmaceuticals |
December, 12 ,2024 | Series C | $120,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Merida Biosciences |
April, 10 ,2025 | Series A | $121,000,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
